| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |